Structural basis for the activity of the type VII CRISPR-Cas system.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 19 03 2024
accepted: 11 07 2024
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

The newly identified type VII CRISPR-Cas candidate system uses a CRISPR RNA-guided ribonucleoprotein complex formed by Cas5 and Cas7 proteins to target RNA

Identifiants

pubmed: 39143216
doi: 10.1038/s41586-024-07815-0
pii: 10.1038/s41586-024-07815-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Altae-Tran, H. et al. Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering. Science 382, eadi1910 (2023).
doi: 10.1126/science.adi1910 pubmed: 37995242 pmcid: 10910872
Hille, F. et al. The biology of CRISPR-Cas: backward and forward. Cell 172, 1239–1259 (2018).
doi: 10.1016/j.cell.2017.11.032 pubmed: 29522745
Makarova, K. S. et al. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2020).
doi: 10.1038/s41579-019-0299-x pubmed: 31857715
Liu, T. Y. & Doudna, J. A. Chemistry of class 1 CRISPR-Cas effectors: binding, editing, and regulation. J. Biol. Chem. 295, 14473–14487 (2020).
doi: 10.1074/jbc.REV120.007034 pubmed: 32817336 pmcid: 7573268
You, L. et al. Structure studies of the CRISPR-Csm complex reveal mechanism of co-transcriptional interference. Cell 176, 239–253.e16 (2019).
doi: 10.1016/j.cell.2018.10.052 pubmed: 30503210
Jia, N. et al. Type III-A CRISPR-Cas Csm complexes: assembly, periodic RNA cleavage, DNase activity regulation, and autoimmunity. Mol. Cell 73, 264–277.e65 (2019).
doi: 10.1016/j.molcel.2018.11.007 pubmed: 30503773
Yu, G. et al. Structure and function of a bacterial type III–E CRISPR-Cas7–11 complex. Nat. Microbiol. 7, 2078–2088 (2022).
doi: 10.1038/s41564-022-01256-z pubmed: 36302881
Wang, S., Guo, M., Zhu, Y., Lin, Z. & Huang, Z. Cryo-EM structure of the type III-E CRISPR-Cas effector gRAMP in complex with TPR-CHAT. Cell Res. 32, 1128–1131 (2022).
doi: 10.1038/s41422-022-00738-3 pubmed: 36280712 pmcid: 9715532
Strecker, J. et al. RNA-activated protein cleavage with a CRISPR-associated endopeptidase. Science 378, 874–881 (2022).
doi: 10.1126/science.add7450 pubmed: 36423276 pmcid: 10028731
Liu, X. et al. Target RNA activates the protease activity of Craspase to confer antiviral defense. Mol. Cell 82, 4503–4518.e8 (2022).
doi: 10.1016/j.molcel.2022.10.007 pubmed: 36306795
Kato, K. et al. RNA-triggered protein cleavage and cell growth arrest by the type III-E CRISPR nuclease-protease. Science 378, 882–889 (2022).
doi: 10.1126/science.add7347 pubmed: 36423304 pmcid: 11126364
Hu, C. et al. Craspase is a CRISPR RNA-guided, RNA-activated protease. Science 377, 1278–1285 (2022).
doi: 10.1126/science.add5064 pubmed: 36007061 pmcid: 10041820
Wang, X. et al. Target RNA-guided protease activity in type III-E CRISPR-Cas system. Nucleic Acids Res. 50, 12913–12923 (2022).
doi: 10.1093/nar/gkac1151 pubmed: 36484100 pmcid: 9825189
Sofos, N. et al. Structures of the Cmr-β complex reveal the regulation of the immunity mechanism of type III-B CRISPR-Cas. Mol Cell. 79, 741–757.e7 (2020).
doi: 10.1016/j.molcel.2020.07.008 pubmed: 32730741
Callebaut, I., Moshous, D., Mornon, J. P. & de Villartay, J. P. Metallo-β-lactamase fold within nucleic acids processing enzymes: the β-CASP family. Nucleic Acids Res. 30, 3592–3601 (2002).
doi: 10.1093/nar/gkf470 pubmed: 12177301 pmcid: 134238
Moshous, D. et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105, 177–186 (2001).
doi: 10.1016/S0092-8674(01)00309-9 pubmed: 11336668
Phung, D. K. et al. RNA processing machineries in Archaea: the 5′–3′ exoribonuclease aRNase J of the β-CASP family is engaged specifically with the helicase ASH-Ski2 and the 3′–5′ exoribonucleolytic RNA exosome machinery. Nucleic Acids Res. 48, 3832–3847 (2020).
doi: 10.1093/nar/gkaa052 pubmed: 32030412 pmcid: 7144898
Zhao, Y. et al. Structural insights into catalysis and dimerization enhanced exonuclease activity of RNase J. Nucleic Acids Res. 43, 5550–5559 (2015).
doi: 10.1093/nar/gkv444 pubmed: 25940620 pmcid: 4477667
Sun, Y. et al. Structure of an active human histone pre-mRNA 3′-end processing machinery. Science 367, 700–703 (2020).
doi: 10.1126/science.aaz7758 pubmed: 32029631 pmcid: 7008720
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
doi: 10.1038/s41586-021-03819-2 pubmed: 34265844 pmcid: 8371605
Wang, Z., Fast, W., Valentine, A. M. & Benkovic, S. J. Metallo-β-lactamase: structure and mechanism. Curr. Opin. Chem. Biol. 3, 614–622 (1999).
doi: 10.1016/S1367-5931(99)00017-4 pubmed: 10508665
Yang, X. C., Sullivan, K. D., Marzluff, W. F. & Dominski, Z. Studies of the 5′ exonuclease and endonuclease activities of CPSF-73 in histone pre-mRNA processing. Mol. Cell. Biol. 29, 31–42 (2009).
doi: 10.1128/MCB.00776-08 pubmed: 18955505
Xiao, Y. et al. Structure basis for directional R-loop formation and substrate handover mechanisms in type I CRISPR-Cas system. Cell 170, 48–60.e11 (2017).
doi: 10.1016/j.cell.2017.06.012 pubmed: 28666122 pmcid: 5841471
O’Brien, R. E. et al. Structural basis for assembly of non-canonical small subunits into type I-C Cascade. Nat. Commun. 11, 5931 (2020).
doi: 10.1038/s41467-020-19785-8 pubmed: 33230133 pmcid: 7684278
Hu, C. et al. Allosteric control of type I–A CRISPR–Cas3 complexes and establishment as effective nucleic acid detection and human genome editing tools. Mol. Cell 82, 2754–2768.e5 (2022).
doi: 10.1016/j.molcel.2022.06.007 pubmed: 35835111 pmcid: 9357151
Schwartz, E. A. et al. Structural rearrangements allow nucleic acid discrimination by type I-D Cascade. Nat. Commun. 13, 2829 (2022).
doi: 10.1038/s41467-022-30402-8 pubmed: 35595728 pmcid: 9123187
O’Brien, R. E. et al. Structural snapshots of R-loop formation by a type I-C CRISPR Cascade. Mol. Cell 83, 746–758.e5 (2023).
doi: 10.1016/j.molcel.2023.01.024 pubmed: 36805026 pmcid: 10026943
Goswami, H. N., Rai, J., Das, A. & Li, H. Molecular mechanism of active Cas7-11 in processing CRISPR RNA and interfering target RNA. eLife 11, e81678 (2022).
doi: 10.7554/eLife.81678 pubmed: 36190192 pmcid: 9629832
Mathy, N. et al. Bacillus subtilis ribonucleases J1 and J2 form a complex with altered enzyme behaviour. Mol. Microbiol. 75, 489–498 (2010).
doi: 10.1111/j.1365-2958.2009.07004.x pubmed: 20025672
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
doi: 10.1038/nmeth.4169 pubmed: 28165473
Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679–682 (2022).
doi: 10.1038/s41592-022-01488-1 pubmed: 35637307 pmcid: 9184281
Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).
doi: 10.1002/pro.4792 pubmed: 37774136 pmcid: 10588335
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
doi: 10.1107/S0907444910007493 pubmed: 20383002 pmcid: 2852313
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
doi: 10.1107/S2059798318006551
Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
doi: 10.1002/pro.3330 pubmed: 29067766
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861–877 (2019).
doi: 10.1107/S2059798319011471

Auteurs

Jie Yang (J)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Xuzichao Li (X)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Qiuqiu He (Q)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Xiaoshen Wang (X)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Jingjing Tang (J)

Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
University of Chinese Academy of Sciences, Beijing, China.

Tongyao Wang (T)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Yi Zhang (Y)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Feiyang Yu (F)

State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.

Shuqin Zhang (S)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Zhikun Liu (Z)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Lingling Zhang (L)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Fumeng Liao (F)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Hang Yin (H)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Haiyan Zhao (H)

State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.

Zengqin Deng (Z)

Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. dengzengqin@wh.iov.cn.
Hubei Jiangxia Laboratory, Wuhan, China. dengzengqin@wh.iov.cn.

Heng Zhang (H)

State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), International Joint Laboratory of Ocular Diseases (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China. zhangheng134@gmail.com.

Classifications MeSH